# Randomized Gefitinib Trial

> **NCT00807066** · PHASE3 · COMPLETED · sponsor: **Fondazione Humanitas per la Ricerca** · enrollment: 1 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Gefitinib
- **DRUG:** Platinum

## Key facts

- **NCT ID:** NCT00807066
- **Lead sponsor:** Fondazione Humanitas per la Ricerca
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-11
- **Final completion:** 2010-10
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2012-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807066, "Randomized Gefitinib Trial". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00807066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*